News · page 7

During the current health crisis, Inserm Legal Affairs Department director Jean-Christophe Hébert and his team have also been highly active in setting up the contracts necessary for the Institute’s COVID-19 research projects. It is in honor of his efficacy that he has been awarded the Innovation Prize. « An Inserm product, through and through » is how […]

An internationally renowned expert in infectious diseases, Anthony Fauci plays a key role in informing the general public on COVID-19, and in terms of strategies and advice on how to best contain the pandemic. It is in recognition of this role that Inserm has awarded him its International Prize. Anthony Fauci was already a « celebrity » […]

Respiratory syncytial virus (RSV) is one of the deadliest respiratory viruses, especially in young children. However, deciphering the mechanisms that allow its entry into the host cell has not led to any effective treatments so far. What if the solution lay downstream of these early stages of the viral cycle? This is the avenue that […]

Respiratory infections are the third leading cause of mortality worldwide, not helped by the emergence of antibiotic resistance in bacterial pneumonia. Jean-Claude Sirard is working on an innovative therapeutic avenue: the administration of a protein component of bacteria to reinforce natural immunity and the efficacy of antibiotic therapy in response to the infection. The researcher […]

When the COVID-19 epidemic began to gather momentum in France back in March 2020, the scientists from the Interferon and Antiviral Restriction team at the Infectious Disease Research Institute of Montpellier did not hesitate for long before tackling the study of its causative virus, SARS-CoV‑2. Six months later, how are they getting on? Join us for […]

Little is known about the biological origin of anxiety and particularly that of pathological anxiety, which affects almost 20% of the population. But thanks to the Atip-Avenir team that she founded two years ago and has been the leader of ever since, Anna Beyeler, Inserm researcher at Neurocentre Magendie in Bordeaux, has challenged herself to […]

The vast majority of people with autism experience unusual phenomena relating to some or all of their senses. For example, they may find contact with some materials to be unbearable. Andreas Frick, Inserm Research Director at Neurocentre Magendie in Bordeaux, is trying to understand the neural dysfunction behind this atypical perception in order to propose […]

Manuel Diaz-Munoz is exploring the mechanisms that regulate the expression of genes involved in immune response and carcinogenesis. In particular, he is studying those involved in the production of antibodies by B cells. These mechanisms have been shown to be altered in many blood cancers and lymphomas: it is therefore essential to understand them in order […]

The Signal and Image Processing Laboratory (LTSI) celebrated its 50th anniversary last November. Intended for military applications when it launched in 1969, this Inserm/Université de Rennes 1 Joint Research Unit now devotes itself entirely to the application of digital sciences to health. « We provide doctors with interpretation and decision-support tools to improve the treatment of […]

At the Signal and Image Processing Laboratory in Rennes, Fabrice Wendling is analyzing and interpreting the brain’s electrical signals to understand how epileptic seizures are triggered and how they develop. After more than 25 years of research in the field, he and his two collaborators have obtained a 10-million-euro European Research Council Synergy Grant to develop […]